The effects of budesonide/formoterol maintenance and reliever therapy on airway inflammation in asthma patients; open label, randomized parallel group comparison study with fluticasone/salmeterol
- Conditions
- Bronchial asthma
- Registration Number
- JPRN-UMIN000011241
- Lead Sponsor
- Hiroshima Allergy and Respiratory Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Not provided
-Patients with a history of hypersensitivity (including contact dermatitis) to any ingredient contained in the study drugs -Patients with infections with no available effective antimicrobial drugs or with deep seated mycosis -Patients with tuberculosis -Patients with rhinitis needed to be treated clinically -Respiratory infection, judged by the investigator as an infection affecting the asthma, within 8 weeks prior to enrollment -Use of any beta-blocking agents (including eye-drops) -Treatment with oral, parenteral or rectal steroids within 30 days prior to enrollment -Any significant disease or disorder judged by the investigator -Current or previous with a smoking history,10 pack years or more, or smoking cessation no longer than 6 months prior to enrollment -Pregnancy, breast-feeding or planned pregnancy during the study -Suspected poor capability, as judged by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in exhaled nitric oxide concentration from before to after 8 weeks treatment
- Secondary Outcome Measures
Name Time Method